High Fatality Rates in Pediatric Multisystem Inflammatory Syndrome: A Multicenter Experience From the Epicenter of Brazil's Coronavirus Pandemic
Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
ALMEIDA, Flavia Jacqueline
JAROVSKY, Daniel
FARIAS, Camila Giuliana Almeida
CASTILHO, Taisa Roberta Ramos Nantes de
CAETANO, Thiago Gara
BORSETTO, Cibele Cristina Manzoni Ribeiro
AGUIAR, Andressa Simoes
ARAUJO, Carolina Serafini de
Citação
PEDIATRIC INFECTIOUS DISEASE JOURNAL, v.43, n.2, p.109-116, 2024
Resumo
Background:Brazil ' s case fatality rate (CFR) of pediatric multisystem inflammatory syndrome in children and adolescents (MIS-C) is among the highest worldwide. Despite these concerns, limited hospital-based and comprehensive pediatric data have been published on MIS-C in Brazilian children.We performed a descriptive analysis of the MIS-C scores in 16 public and private hospitals providing secondary and tertiary care in the metropolitan area of Sao Paulo, Brazil. Clinical and demographic information were systematically extracted from the electronic medical records of each patient. Logistic regression analysis was performed to identify the combined effects of MIS-C phenotype, disease severity and comorbidity as dependent variables.A total of 101 patients met the MIS-C criteria and were evaluated. The median age was 67 months, 60% were male, 28.7% were black or afrodescendant and 62.3% were admitted to public hospitals. Underlying medical conditions were observed in 16.8% of patients and were associated with a longer duration of hospitalization. A Kawasaki disease-like phenotype was observed in 43.5% of patients, and they demonstrated a trend of lower median age. Children with severe MIS-C were older (median age 91 months vs. 36 months) and had a nonspecific phenotype, more cardiovascular and respiratory involvement and kidney injury; 73.3% required intensive care, 20.8% required mechanical ventilation and 35.6% required inotropic support. Four deaths occurred (CFR = 3.9%), three of which were in healthy participants.We identified a lower median age, particularly among children with Kawasaki disease-like phenotypes, those with a significant need for intensive care, and a high CFR in MIS-C. Our findings confirmed the increased severity of the disease in the selected Brazilian population.Background:Brazil ' s case fatality rate (CFR) of pediatric multisystem inflammatory syndrome in children and adolescents (MIS-C) is among the highest worldwide. Despite these concerns, limited hospital-based and comprehensive pediatric data have been published on MIS-C in Brazilian children.We performed a descriptive analysis of the MIS-C scores in 16 public and private hospitals providing secondary and tertiary care in the metropolitan area of Sao Paulo, Brazil. Clinical and demographic information were systematically extracted from the electronic medical records of each patient. Logistic regression analysis was performed to identify the combined effects of MIS-C phenotype, disease severity and comorbidity as dependent variables.A total of 101 patients met the MIS-C criteria and were evaluated. The median age was 67 months, 60% were male, 28.7% were black or afrodescendant and 62.3% were admitted to public hospitals. Underlying medical conditions were observed in 16.8% of patients and were associated with a longer duration of hospitalization. A Kawasaki disease-like phenotype was observed in 43.5% of patients, and they demonstrated a trend of lower median age. Children with severe MIS-C were older (median age 91 months vs. 36 months) and had a nonspecific phenotype, more cardiovascular and respiratory involvement and kidney injury; 73.3% required intensive care, 20.8% required mechanical ventilation and 35.6% required inotropic support. Four deaths occurred (CFR = 3.9%), three of which were in healthy participants.We identified a lower median age, particularly among children with Kawasaki disease-like phenotypes, those with a significant need for intensive care, and a high CFR in MIS-C. Our findings confirmed the increased severity of the disease in the selected Brazilian population.Background:Brazil ' s case fatality rate (CFR) of pediatric multisystem inflammatory syndrome in children and adolescents (MIS-C) is among the highest worldwide. Despite these concerns, limited hospital-based and comprehensive pediatric data have been published on MIS-C in Brazilian children.We performed a descriptive analysis of the MIS-C scores in 16 public and private hospitals providing secondary and tertiary care in the metropolitan area of Sao Paulo, Brazil. Clinical and demographic information were systematically extracted from the electronic medical records of each patient. Logistic regression analysis was performed to identify the combined effects of MIS-C phenotype, disease severity and comorbidity as dependent variables.A total of 101 patients met the MIS-C criteria and were evaluated. The median age was 67 months, 60% were male, 28.7% were black or afrodescendant and 62.3% were admitted to public hospitals. Underlying medical conditions were observed in 16.8% of patients and were associated with a longer duration of hospitalization. A Kawasaki disease-like phenotype was observed in 43.5% of patients, and they demonstrated a trend of lower median age. Children with severe MIS-C were older (median age 91 months vs. 36 months) and had a nonspecific phenotype, more cardiovascular and respiratory involvement and kidney injury; 73.3% required intensive care, 20.8% required mechanical ventilation and 35.6% required inotropic support. Four deaths occurred (CFR = 3.9%), three of which were in healthy participants.We identified a lower median age, particularly among children with Kawasaki disease-like phenotypes, those with a significant need for intensive care, and a high CFR in MIS-C. Our findings confirmed the increased severity of the disease in the selected Brazilian population.Background:Brazil ' s case fatality rate (CFR) of pediatric multisystem inflammatory syndrome in children and adolescents (MIS-C) is among the highest worldwide. Despite these concerns, limited hospital-based and comprehensive pediatric data have been published on MIS-C in Brazilian children.We performed a descriptive analysis of the MIS-C scores in 16 public and private hospitals providing secondary and tertiary care in the metropolitan area of Sao Paulo, Brazil. Clinical and demographic information were systematically extracted from the electronic medical records of each patient. Logistic regression analysis was performed to identify the combined effects of MIS-C phenotype, disease severity and comorbidity as dependent variables.A total of 101 patients met the MIS-C criteria and were evaluated. The median age was 67 months, 60% were male, 28.7% were black or afrodescendant and 62.3% were admitted to public hospitals. Underlying medical conditions were observed in 16.8% of patients and were associated with a longer duration of hospitalization. A Kawasaki disease-like phenotype was observed in 43.5% of patients, and they demonstrated a trend of lower median age. Children with severe MIS-C were older (median age 91 months vs. 36 months) and had a nonspecific phenotype, more cardiovascular and respiratory involvement and kidney injury; 73.3% required intensive care, 20.8% required mechanical ventilation and 35.6% required inotropic support. Four deaths occurred (CFR = 3.9%), three of which were in healthy participants. We identified a lower median age, particularly among children with Kawasaki disease-like phenotypes, those with a significant need for intensive care, and a high CFR in MIS-C. Our findings confirmed the increased severity of the disease in the selected Brazilian population.
Palavras-chave
SARS-CoV-2, COVID-19, MIS-C, hospital-based surveillance, Pediatric, Brazil
Referências
- [Anonymous], 2020, Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19
- [Anonymous], 2014, Epidemiological update: outbreak of Ebola virus disease in West Africa
- [Anonymous], Secretaria de Vigilancia Sanitaria
- Barros LAF, 2023, J PEDIAT-BRAZIL, V99, P31, DOI 10.1016/j.jped.2022.04.003
- Belay ED, 2021, JAMA PEDIATR, V175, P837, DOI 10.1001/jamapediatrics.2021.0630
- CDC National Notifiable Diseases Surveillance System (NNDSS), 2023, Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 Infection (2023 Case Definition)
- Channon-Wells S, 2023, LANCET RHEUMATOL, V5, pE184, DOI 10.1016/S2665-9913(23)00029-2
- Chou JE, 2021, J ALLERGY CLIN IMMUN, V148, P732, DOI 10.1016/j.jaci.2021.06.024
- Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016
- da Costa MA, 2023, ARCH VIROL, V168, DOI 10.1007/s00705-023-05748-z
- e-SUS VE/DVE/COVISA/SMS-SP, TabNet Win32 2.7-COVID19 e-SUS-VE Sindrome Gripal
- Ebina-Shibuya R, 2020, INT J INFECT DIS, V97, P371, DOI 10.1016/j.ijid.2020.06.014
- Fabi M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231710106
- Hoste L, 2021, EUR J PEDIATR, V180, P2019, DOI 10.1007/s00431-021-03993-5
- Instituto Brasileiro de Geografia e Estatistica, 2019, Pesquisa Nacional de Saude 2019
- Jarovsky D, 2023, IJID REG, V7, P52, DOI 10.1016/j.ijregi.2022.12.003
- Lima-Setta F, 2021, J PEDIAT-BRAZIL, V97, P354, DOI 10.1016/j.jped.2020.10.008
- McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
- Miller AD, 2022, CLIN INFECT DIS, V75, pE1165, DOI 10.1093/cid/ciab1007
- Ministerio da Saude, 2022, Boletins Epidemiologicos COVID-19
- Ministerio da Saude Secretaria de Vigilancia em Saude, 2023, Boletim Epidemiologico No 147-Boletim COE Coronavirus-Semanas Epidemiologicas 1 a 4 (2023)
- Moura EC de., 2022, Saude em debate, V46, P682
- PAHO/WHO, 2021, Epidemiological Update: Coronavirus disease (COVID-19)
- Relvas-Brandt LA., 2021, Epidemiol Serv Saude, V30, pe2021267
- Riphagen S, 2020, LANCET, V395, P1607, DOI 10.1016/50140-6736(20)31094-1
- Rowley AH, 2020, NAT REV IMMUNOL, V20, P453, DOI 10.1038/s41577-020-0367-5
- Santos MO, 2022, J PEDIAT-BRAZIL, V98, P338, DOI 10.1016/j.jped.2021.08.006
- Santos-Rebouças CB, 2022, MOL MED, V28, DOI 10.1186/s10020-022-00583-5
- Shi QL, 2021, ECLINICALMEDICINE, V41, DOI 10.1016/j.eclinm.2021.101155
- Torres JP, 2020, INT J INFECT DIS, V100, P75, DOI 10.1016/j.ijid.2020.08.062
- UNICEF, 2022, Child mortality and COVID-19
- Valverde I, 2021, CIRCULATION, V143, P21, DOI 10.1161/CIRCULATIONAHA.120.050065
- Ward JL, 2022, NAT MED, V28, P193, DOI 10.1038/s41591-021-01627-9
- WHO, Case Report Form for suspected cases of multisystem inflammatory syndrome (MIS) in children and adolescents temporally related to COVID-19
- World Health Organization, 2021, Obesity and overweight, DOI 10.1080/10810730903279694